Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ZIM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA ZIM LABORATORIES AUROBINDO PHARMA/
ZIM LABORATORIES
 
P/E (TTM) x 14.3 17.8 80.4% View Chart
P/BV x 1.4 2.2 65.3% View Chart
Dividend Yield % 1.5 0.0 -  

Financials

 AUROBINDO PHARMA   ZIM LABORATORIES
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-22
ZIM LABORATORIES
Mar-21
AUROBINDO PHARMA/
ZIM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,064131 809.2%   
Low Rs58453 1,105.4%   
Sales per share (Unadj.) Rs400.3189.2 211.6%  
Earnings per share (Unadj.) Rs45.74.5 1,014.4%  
Cash flow per share (Unadj.) Rs64.914.2 456.4%  
Dividends per share (Unadj.) Rs9.000-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs419.499.0 423.7%  
Shares outstanding (eoy) m585.9416.24 3,608.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.10.5 422.6%   
Avg P/E ratio x18.020.5 88.1%  
P/CF ratio (eoy) x12.76.5 195.9%  
Price / Book Value ratio x2.00.9 211.0%  
Dividend payout %19.70-   
Avg Mkt Cap Rs m482,7991,497 32,257.8%   
No. of employees `000NANA-   
Total wages/salary Rs m34,509358 9,649.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m234,5553,073 7,633.7%  
Other income Rs m3,22623 13,803.2%   
Total revenues Rs m237,7813,096 7,680.3%   
Gross profit Rs m42,566346 12,308.6%  
Depreciation Rs m11,265158 7,134.8%   
Interest Rs m486109 446.3%   
Profit before tax Rs m34,040102 33,271.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,25629 24,901.5%   
Profit after tax Rs m26,78473 36,599.6%  
Gross profit margin %18.111.3 161.2%  
Effective tax rate %21.328.5 74.9%   
Net profit margin %11.42.4 479.5%  
BALANCE SHEET DATA
Current assets Rs m181,2271,918 9,450.7%   
Current liabilities Rs m81,5601,420 5,742.2%   
Net working cap to sales %42.516.2 262.6%  
Current ratio x2.21.4 164.6%  
Inventory Days Days2516 159.5%  
Debtors Days Days62858 7.3%  
Net fixed assets Rs m155,1041,304 11,891.9%   
Share capital Rs m586162 360.7%   
"Free" reserves Rs m245,1741,445 16,966.1%   
Net worth Rs m245,7601,608 15,288.3%   
Long term debt Rs m2,492218 1,141.6%   
Total assets Rs m336,3313,222 10,438.9%  
Interest coverage x71.01.9 3,661.2%   
Debt to equity ratio x00.1 7.5%  
Sales to assets ratio x0.71.0 73.1%   
Return on assets %8.15.7 143.4%  
Return on equity %10.94.6 239.4%  
Return on capital %13.911.6 120.2%  
Exports to sales %31.167.4 46.1%   
Imports to sales %11.94.1 287.4%   
Exports (fob) Rs m72,8622,072 3,516.0%   
Imports (cif) Rs m27,965127 21,943.4%   
Fx inflow Rs m77,2452,140 3,610.0%   
Fx outflow Rs m31,524127 24,736.1%   
Net fx Rs m45,7212,012 2,272.1%   
CASH FLOW
From Operations Rs m50,165319 15,749.8%  
From Investments Rs m-32,116-59 54,609.1%  
From Financial Activity Rs m-29,693-260 11,431.7%  
Net Cashflow Rs m-11,674-1 1,691,884.1%  

Share Holding

Indian Promoters % 48.8 33.3 146.6%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 38.0 0.0 -  
FIIs % 20.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 66.7 72.2%  
Shareholders   359,684 3,569 10,078.0%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    



Today's Market

Sensex Zooms 130 Points, Nifty Ends Above 17,600; Financial and IT Stocks Rally(Closing)

Indian benchmark indices ended on a positive note amid a highly volatile session. This was on the back of metal stocks along with banking and financials.